Abstract
Surgery and radiation therapy are the standard for local tumour control in the treatment of soft tissue sarcoma. Sarcoma recurrence within a previously irradiated area is one of the most problematic therapeutic challenges in soft tissue tumours. Any information on previous therapy needs to be available in detail. In case of recurrent sarcoma not amenable to surgical resection with wide and clear margins, a multimodality therapy needs to be applied. The armamentarium usually looks for a neoadjuvant downstaging of the sarcoma by radiotherapy, chemo-radiotherapy or isolated limb perfusion with all of those strategies bearing benefits, but also specific risks. The potential of repeated radiotherapy and the modality that can be used (intraoperative radiotherapy, brachytherapy) needs to be carefully evaluated. The pathologist saves these major problems in intraoperative frozen section histology or resection margins and thus needs to be aware of the type of cancer cells potentially present within the resection specimen. Plastic and reconstructive surgery to cover the area of re-resection with viable and well-v tissue is absolutely crucial to prevent lymphatic fistula. Thus, adequate treatment of those specific situations usually involves postoperative physiotherapy and a specific rehabilitation, which is extremely important.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig B W, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PW (2007) Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys 67:158–163
Bujko K, Suit HD, Springfield DS, Convery K (1993) Wound healing after preoperative radiation for sarcoma of soft tissues. Surg Gynecol Obstet 176:124–134
Cannon C P, Ballo MT, Zagars GK, Mirza AN, Lin P P, Lewis VO, Yasko AW, Benjamin RS, Pisters PW (2006) Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461
Catton C, Davis A, Bell R, O'Sullivan B, Fornasier V, Wunder J, McLean M (1996) Soft tissue sarcoma of the extremity. Limb salvage after failure of combined conservative therapy. Radiother Oncol 41:209–214
Davis AM, O'Sullivan B, Bell RS, Turcotte R, Catton CN, Wunder JS, Chabot P, Hammond A, Benk V, Isler M, Freeman C, Doddard K, Bezjak A, Kandel RA, Sadura A, Day A, James K, Tu D, Pater J, Zee B (2002) Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma. J Clin Oncol 20:4472–4477
Davis AM, O'Sullivan B, Turcotte R, Bell R, Catton C, Chabot P, Wunder JS, Hammond A, Benk V, Kandel R, Goddard K, Freeman C, Sadura A, Zee B, Day A, Tu D, Pater J (2005) Canadian Sarcoma Group; NCI Canada Clinical Trial Group Randomized Trial. Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53
Eggermont AM, Schraffordt Koops H, Klausner JM, Kroon BB, Schlag PM, Lienard D, van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector C, Lejeune FJ (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. J Clin Oncol 14:2653–2665
Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN, Ezzat A, Santoro A, Oosterhuis J W, van Glabbeke M, Kirkpatrick A, Verweij J (2001) A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma. Eur J Cancer 37:1096–1103
Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D’Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG (2007) Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol 8:595–602
Gutman M, Inbar M, Lev-Shlush D, Abu-Abid S, Mozes M, Chaitchik S, Meller I, Klausner JM (1997) High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79:1129–1137
Hohenberger P, Wysocki WM (2008) Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose? Oncologist 13:175–186
Hünerbein M, Hohenberger P, Stroszczynski C, Bartelt N, Schlag PM, Tunn PU (2007) Resection of soft tissue sarcoma of the lower limb after evaluation of vascular invasion with intraopera- tive intravascular ultrasonography. Br J Surg 94:168–173
Issels R, Abdel-Rahman S, Wendtner C, alk MH, Kurze V, Sauer H, Aydemir U, Hiddemann W (2001) Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. Eur J Cancer 37:1587–1589
Issels RD, Lindner LH, Wust P, Hohenberger P, Jauch K W, Daugaard S, Mansmann U, Hiddemann W, Blay J Y, Verweij J (2007) Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO inter- group trial). Proc Am Soc Clin Oncol 25:10009
Lans TE, Grünhagen DJ, deWilt JH, van Geel AN, Eggermont AM (2005) Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs. Ann Surg Oncol 12:406–411
Lin PP, Schupak KD, Boland PJ, Brennan MF, Healey JH (1998) Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer 82:2356–2365
Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BBR (2003) Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer 98:1483–1490
O'Sullivan B, Davies AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241
Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PW (1999) Re-resection with brachyther- apy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am 5:26–33
Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin P P, Zagars G, Wei C, Ballo MT (2007) Long- term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg 246:675–681
Riedel F, Philipp K, Sadick H, Goessler U, Hörmann K, Verse T (2005) Immuno- histochemical analysis of radiation-induced non-healing dermal wounds of the head and neck. In Vivo 19:343–350
Springfield DS (1993) Surgical wound healing. Cancer Treat Res 1993 67:81–89
Temple CL, Ross DC, Magi E, DiFrancesco M, Kurien E, Temple WJ (2007) Preoperative chemoradiation and flap reconstruction provide high local control and low wound complication rates for patients undergoing limb salvage surgery for upper extremity tumors. J Surg Oncol 95:135–141
Torres MA, Ballo MT, Butler CE, Feig B W, Cormier JN, Lewis VO, Pollock RE, Pisters P W, Zagars GK (2007) Management of locally recurrent soft-tissue sarcoma after prior surgery and radiation therapy. Int J Radiat Oncol Biol Phys 67:1124–1129
Trovik CS, Bauer HC, Alvegård TA, Anderson H, Blomquist C, Berlin O, Gustafson P, Saeter G, Wallöe A (2000) Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer 36:710–716
Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3:487–497
Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, DeLaney T, Glatstein E, Steinberg SM, Merino MJ, Rosenberg SA (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hohenberger, P., Schwarzbach, M.H. (2009). Management of Locally Recurrent Soft Tissue Sarcoma after Prior Surgery and Radiation Therapy. In: Tunn, PU. (eds) Treatment of Bone and Soft Tissue Sarcomas. Recent Results in Cancer Research, vol 179. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77960-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-540-77960-5_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77959-9
Online ISBN: 978-3-540-77960-5
eBook Packages: MedicineMedicine (R0)